Authors' response

Affiliations

¹ Department of Infectious Diseases, Christian Medical College, Vellore 632 004, Tamil Nadu, India.
² Department of General Medicine & Infectious Diseases, Christian Medical College, Vellore 632 004, Tamil Nadu, India.

Comment

George M Varghese et al. Indian J Med Res. 2020.

. 2020;152(1 & 2):151-152.

doi: 10.4103/0971-5916.294037.

¹ Department of Infectious Diseases, Christian Medical College, Vellore 632 004, Tamil Nadu, India.
² Department of General Medicine & Infectious Diseases, Christian Medical College, Vellore 632 004, Tamil Nadu, India.

No abstract available

Conflict of interest statement

None

Clinical management of COVID-19.
Varghese GM, John R, Manesh A, Karthik R, Abraham OC. Varghese GM, et al. Indian J Med Res. 2020 May;151(5):401-410. doi: 10.4103/ijmr.IJMR_957_20. Indian J Med Res. 2020. PMID: 32611911 Free PMC article. Review.
Recent developments in COVID-19 therapeutics & current evidence for COVID-19-associated multisystem inflammatory syndrome.
Gupta S, Kaushik A, Sood M. Gupta S, et al. Indian J Med Res. 2020 Jul & Aug;152(1 & 2):149-151. doi: 10.4103/ijmr.IJMR_2785_20. Indian J Med Res. 2020. PMID: 32883919 Free PMC article. No abstract available.

1. Gupta S, Kaushik A, Sood M. Recent developments in COVID-19 therapeutics & current evidence for COVID-19-associated multisystem inflammatory syndrome. Indian J Med Res. 2020;152:149–51. - PMC - PubMed
1. Beigel JH, Tomashek KM, Dodd LE, Mehta AK, Zingman BS, Kalil AC, et al. Remdesivir for the Treatment of COVID-19 - Preliminary. N Engl J Med. 2020 NEJMoa2007764. - PubMed
1. Recovery Collaborative Group. Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, et al. Dexamethasone in hospitalized patients with COVID-19 - preliminary report. N Engl J Med. 2020 NEJMoa2021436. - PMC - PubMed
1. World Health Organization. ”Solidarity” clinical trials for COVID-19 treatments. [accessed on August 9, 2020]. Available from: https://wwwwhoint/emergencies/diseases/novel-coronavirus-2019/global-res... .
1. Roche provides an update on the phase III COVACTA trial of Actemra/RoActemra in hospitalised patients with severe COVID-19 associated pneumonia. [accessed on August 12, 2020]. Available from: https://wwwrochecom/investors/updates/inv-update-2020-07-29htm .